24.22USD+3.73%Mkt Cap: 969.53M USDP/E: 189.54Last update: 2026-05-26
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The co…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap969.53M USD
Enterprise Value1.13B USD
Revenue (TTM)734.86M USD
Gross Profit576.66M USD
Net Income (TTM)7.03M USD
Revenue/Share17.05 USD
Last Price24.22 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees825
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS6951271005
Valuation
P/E (Trailing)189.54
P/E (Forward)6.45
PEG11.21
EV/EBITDA9.34
EV/Revenue1.54
P/S1.26
P/B1.41
EPS (TTM)0.13
EPS (Forward)3.64
52W Range
18.8061% of range27.64
52W High27.64 USD
52W Low18.80 USD
Profitability
Gross Margin79.39%
Oper. Margin2.61%
EBITDA Margin16.50%
Profit Margin0.97%
ROE1.01%
ROA0.56%
Growth
Revenue Growth5.00%
Earnings Growth-30.00%
Cash Flow & Leverage
Operating CF151.99M USD
CapEx (TTM)15.33M USD
FCF Margin13.42%
FCF Yield10.17%
Net Debt209.00M USD
Net Debt/EBITDA1.72
Balance Sheet
Debt/Equity0.60
Current Ratio4.73
Quick Ratio3.01
Book Value/Sh16.63 USD
Cash/Share5.138 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Target (Mean)29.29 USD
Target Range23.00 USD – 38.00 USD
# Analysts7
Ownership
Shares Out.39.35M
Float33.67M
Insiders1.74%
Institutions115.57%
Short Interest
Short Ratio14.9d
Short % Float28.62%
Short % Out.19.80%
Shares Short7.79M
Short (prev mo.)8.06M
Technical
SMA 5023.54 (+2.9%)
SMA 20023.72 (+2.1%)
Beta0.32
S&P 52W Chg28.31%
Avg Vol (30d)579.17K
Avg Vol (10d)502.07K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—